Author(s):
Mohammad Naanaa, Faten Sliman, Hala Barakat
Email(s):
muhamed.nanaa@tishreen.edu.sy. , fatensliman@tartous-univ.edu.sy. , halabarakat@tishreen.edu.sy.
DOI:
10.52711/0974-360X.2026.00295
Address:
Mohammad Naanaa1*, Faten Sliman2, Hala Barakat3
1Master Student in Pharmaceutical Chemistry and Quality Control Department, Faculty of Pharmacy, Latakia University, Syria.
2Professor in in Pharmaceutical Chemistry and Quality Control Department, Faculty of Pharmacy, Tartous University, Syria.
3Professor in in Pharmaceutical Chemistry and Quality Control Department, Faculty of Pharmacy, Latakia, Syria
*Corresponding Author
Published In:
Volume - 19,
Issue - 5,
Year - 2026
Cite this article:
Mohammad Naanaa, Faten Sliman, Hala Barakat. QSAR Study for Developing a New c-SRC Tyrosine Kinase Inhibitors. Research Journal Pharmacy and Technology. 2026;19(5):2059-4. doi: 10.52711/0974-360X.2026.00295